US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
EP2036558A3
(de)
*
|
1993-10-07 |
2010-04-28 |
Euro-Celtique S.A. |
Oral anzuwendende opioidhaltige Zusammensetzungen mit verlängerter Wirkung
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
DE69618956T2
(de)
*
|
1995-06-09 |
2002-08-22 |
Scherer Technologies Inc R P |
Weichgelatinekapsel mit teilchenmaterial
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
US5733578A
(en)
*
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
US5939356A
(en)
*
|
1996-06-21 |
1999-08-17 |
Southwest Research Institute |
Controlled release coated agricultural products
|
WO1998010756A1
(fr)
*
|
1996-09-13 |
1998-03-19 |
Shionogi & Co., Ltd. |
Preparation a liberation prolongee faisant appel au changement thermique et procede de fabrication
|
US5807580A
(en)
*
|
1996-10-30 |
1998-09-15 |
Mcneil-Ppc, Inc. |
Film coated tablet compositions having enhanced disintegration characteristics
|
US6180128B1
(en)
*
|
1997-01-27 |
2001-01-30 |
C-Cure Corp. |
Non-carcinogenic substitute for play sand
|
WO1999001111A1
(en)
|
1997-07-02 |
1999-01-14 |
Euro-Celtique, S.A. |
Stabilized sustained release tramadol formulations
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
WO1999019085A1
(en)
*
|
1997-10-15 |
1999-04-22 |
University Of South Florida |
Supercritical fluid aided coating of particulate material
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
US6485748B1
(en)
*
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
ES2415876T3
(es)
|
1997-12-22 |
2013-07-29 |
Euro-Celtique S.A. |
Forma de dosificación farmacéutica oral que comprende una combinación de un agonista de opiáceos y un antagonista de opiáceos
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6245357B1
(en)
*
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US5976507A
(en)
*
|
1998-06-04 |
1999-11-02 |
Colgate Palmolive Company |
Dentrifice composition containing encapsulated reactive ingredients
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
DE19901686A1
(de)
*
|
1999-01-18 |
2000-07-20 |
Gruenenthal Gmbh |
Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6432448B1
(en)
*
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
JP2003509439A
(ja)
*
|
1999-09-14 |
2003-03-11 |
スミスクライン・ビーチャム・コーポレイション |
水性コーティングされたビーズレットの製法
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
IL149352A0
(en)
|
1999-10-29 |
2002-11-10 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
CN101703777B
(zh)
|
2000-02-08 |
2012-11-28 |
欧罗赛铁克股份有限公司 |
抗破坏口服阿片样激动剂
|
DE60135441D1
(de)
|
2000-02-08 |
2008-10-02 |
Euro Celtique Sa |
Zusammensetzungen mit kontrollierter freisetzung, die einen opioid agonist und antagonist enthalten
|
GB0007419D0
(en)
†
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
SE0001151D0
(sv)
|
2000-03-31 |
2000-03-31 |
Amarin Dev Ab |
Method for producing a controlled-release composition
|
US6635277B2
(en)
|
2000-04-12 |
2003-10-21 |
Wockhardt Limited |
Composition for pulsatile delivery of diltiazem and process of manufacture
|
US6663686B1
(en)
*
|
2000-06-27 |
2003-12-16 |
Agrium, Inc. |
Controlled release fertilizer and method for production thereof
|
JP2004512354A
(ja)
|
2000-10-30 |
2004-04-22 |
ユーロ−セルティーク,エス.エイ. |
ヒドロコドン放出制御製剤
|
BR0115585A
(pt)
|
2000-11-28 |
2005-12-13 |
Fmc Corp |
Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
|
US6486248B2
(en)
|
2001-01-08 |
2002-11-26 |
Milliken & Company |
Liquid colorant and method
|
US6878309B2
(en)
*
|
2001-02-12 |
2005-04-12 |
Dober Chemical Corp. |
Controlled release cooling additive composition
|
AU2002248792B2
(en)
*
|
2001-04-18 |
2006-09-21 |
Nostrum Pharmaceuticals Inc. |
A novel coating for a sustained release pharmaceutical composition
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
EP1387673B1
(de)
|
2001-05-11 |
2010-12-29 |
Endo Pharmaceuticals Inc. |
Opioid enthaltende arzneiform gegen missbrauch
|
US20030070584A1
(en)
*
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US7052706B2
(en)
*
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
PT1416842E
(pt)
|
2001-07-18 |
2009-03-31 |
Euro Celtique Sa |
Composições farmacêuticas de oxicodona e naloxona
|
KR20040029405A
(ko)
|
2001-08-06 |
2004-04-06 |
유로-셀티크 소시에떼 아노뉨 |
방출성 및 격리된 길항제와 오피오이드 효능제의 제제
|
WO2003013433A2
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
EP1429728A1
(de)
*
|
2001-08-29 |
2004-06-23 |
SRL Technologies, Inc. |
Zubereitungen mit verzögerter freisetzung
|
JP4925526B2
(ja)
*
|
2001-09-10 |
2012-04-25 |
旭化成ケミカルズ株式会社 |
薬物の混合方法
|
US8282955B2
(en)
|
2001-10-15 |
2012-10-09 |
Ferring B.V. |
Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
|
IL146462A
(en)
|
2001-11-13 |
2015-02-26 |
Lycored Bio Ltd |
Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
|
FR2832632B1
(fr)
|
2001-11-26 |
2004-04-23 |
Mane Fils V |
Capsule a solubilisation et liberation du contenu rapides
|
US20030118647A1
(en)
*
|
2001-12-04 |
2003-06-26 |
Pawan Seth |
Extended release tablet of metformin
|
US7790905B2
(en)
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
AU2003213719A1
(en)
|
2002-03-01 |
2003-09-16 |
Regents Of The University Of Michigan |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
EP3241548A1
(de)
|
2002-04-05 |
2017-11-08 |
Euro-Celtique S.A. |
Matrix für nachhaltige, invariante und unabhängige freisetzung von wirkstoffverbindungen
|
US6958161B2
(en)
*
|
2002-04-12 |
2005-10-25 |
F H Faulding & Co Limited |
Modified release coated drug preparation
|
EP1515703A1
(de)
|
2002-06-21 |
2005-03-23 |
Transform Pharmaceuticals, Inc. |
Pharmazeutische zusammensetzungen mit verbesserter auflösung
|
US7771707B2
(en)
|
2004-06-12 |
2010-08-10 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
AR040680A1
(es)
*
|
2002-07-25 |
2005-04-13 |
Pharmacia Corp |
Composicion de tabletas de liberacion sostenida
|
PA8578501A1
(es)
*
|
2002-07-25 |
2005-02-04 |
Pharmacia Corp |
Forma de dosificacion una vez al dia de pramipexol
|
US20050226926A1
(en)
|
2002-07-25 |
2005-10-13 |
Pfizer Inc |
Sustained-release tablet composition of pramipexole
|
EP1526843A1
(de)
*
|
2002-07-25 |
2005-05-04 |
Pharmacia Corporation |
Verfahren zur herstellung fester dosierformen mit einem zweischichtigen überzug aus einem wasserunlöslichen polymer und einem wasserlöslichen porenbildner
|
US20040016276A1
(en)
*
|
2002-07-26 |
2004-01-29 |
Wynnyk Nick P. |
Controlled release fertilizer having improved mechanical handling durability and method for production thereof
|
DE60335557D1
(de)
|
2002-08-15 |
2011-02-10 |
Euro Celtique Sa |
Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum
|
US20040043064A1
(en)
*
|
2002-08-29 |
2004-03-04 |
Iorio Theodore L. |
Dosage forms having reduced moisture transmission
|
AU2003267231A1
(en)
*
|
2002-09-20 |
2004-04-08 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US7815934B2
(en)
|
2002-09-20 |
2010-10-19 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
ES2206047B1
(es)
*
|
2002-10-22 |
2005-08-01 |
Universidad De Granada |
Sintesis de un transportador de morfina para formas farmaceuticas liquidas orales de accion controlada.
|
AU2003295846A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
ES2350689T3
(es)
|
2002-12-13 |
2011-01-26 |
Durect Corporation |
Sistema de suministro de fármacos oral que comprende materiales vehículo líquidos de alta viscosidad.
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
EP2339328A3
(de)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
MXPA05011071A
(es)
|
2003-04-21 |
2005-12-12 |
Euro Celtique Sa |
Forma de dosificacion resistente a la alteracion que comprende particulas co-extrusionadas de agente adverso y proceso de fabricacion de las misma.
|
US20070042143A1
(en)
*
|
2003-04-23 |
2007-02-22 |
Ferring B.V. |
Sachet for a pharmaceutical composition
|
GB2402679A
(en)
*
|
2003-06-10 |
2004-12-15 |
Reckitt Benckiser Nv |
Automatic washing machine detergent dispensing device
|
US7632521B2
(en)
*
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
FR2859729B1
(fr)
*
|
2003-09-12 |
2006-02-24 |
Roquette Freres |
Dispersions aqueuses d'au moins un polymere biodegradable
|
PL1663229T3
(pl)
|
2003-09-25 |
2010-09-30 |
Euro Celtique Sa |
Farmaceutyczne kombinacje hydrokodonu i naltreksonu
|
PT1691892E
(pt)
*
|
2003-12-09 |
2007-05-31 |
Euro Celtique Sa |
Forma posológica co-extrusada inviolável que contém um componente activo e um componente de acção contrária e um processo para a sua fabricação
|
US8883204B2
(en)
*
|
2003-12-09 |
2014-11-11 |
Purdue Pharma L.P. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
PT1691811E
(pt)
|
2003-12-11 |
2014-10-30 |
Sunovion Pharmaceuticals Inc |
Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
|
EP1547601A1
(de)
*
|
2003-12-23 |
2005-06-29 |
Ferring B.V. |
Beschichtungsverfahren
|
CN1938004B
(zh)
*
|
2004-03-30 |
2011-12-21 |
欧洲凯尔特公司 |
包含吸附剂和不利剂的抗篡改剂型
|
TW201509943A
(zh)
*
|
2004-03-30 |
2015-03-16 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
EP1604667A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung des Restless Leg Syndroms
|
EP1604666A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
PT1789021E
(pt)
*
|
2004-08-13 |
2011-12-22 |
Boehringer Ingelheim Int |
Formulação de comprimidos de libertação prolongada contendo pramipexole ou um seu sal farmaceuticamente aceitável
|
JP4971159B2
(ja)
*
|
2004-08-13 |
2012-07-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
プラミペキソール又はその薬学的に許容しうる塩を含有する徐放性ペレット製剤、その製法及び使用
|
EP1786404A2
(de)
|
2004-09-01 |
2007-05-23 |
Euro-Celtique S.A. |
Opioid-dosierformen mit steady-state-cave proportional zur dosierung und auc und einzeldosen-cmax geringer als proportional zur dosierung
|
US20060093629A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Buehler Gail K |
Dye-free pharmaceutical suspensions and related methods
|
GB0427455D0
(en)
*
|
2004-12-15 |
2005-01-19 |
Jagotec Ag |
Dosage forms
|
DE05815688T1
(de)
*
|
2005-01-27 |
2008-06-26 |
Alembic Ltd. |
Levetiracetam-formulierung mit verlängerter freisetzung
|
CN101132772B
(zh)
*
|
2005-01-28 |
2012-05-09 |
欧洲凯尔特公司 |
耐醇剂型
|
EP1702558A1
(de)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
EP1695700A1
(de)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Darreichungsform enthaltend Oxycodon und Naloxon
|
EP1754471A1
(de)
|
2005-08-18 |
2007-02-21 |
ORAMON-Arzneimittel GmbH & Co. KG |
Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
|
EP1813276A1
(de)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Manipulationssichere Dosierformen
|
DK3095447T3
(da)
|
2006-02-03 |
2022-01-31 |
Opko Renal Llc |
Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
|
WO2007092718A2
(en)
*
|
2006-02-07 |
2007-08-16 |
Fmc Corporation |
Coating process to produce controlled release coatings
|
US20090098202A1
(en)
*
|
2006-02-10 |
2009-04-16 |
Boehringer Ingelheim International Gmbh |
Extended Release Formulation
|
US20090041844A1
(en)
*
|
2006-02-10 |
2009-02-12 |
Boehringer Ingelheim International Gmbh |
Modified Release Formulation
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
FR2897267A1
(fr)
*
|
2006-02-16 |
2007-08-17 |
Flamel Technologies Sa |
Formes pharmaceutiques multimicroparticulaires pour administration per os
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
HUE032156T2
(en)
|
2006-06-19 |
2017-09-28 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical preparations
|
PL2679228T3
(pl)
|
2006-06-21 |
2018-07-31 |
Opko Ireland Global Holdings, Ltd. |
Terapia z użyciem środka do uzupełniania witaminy D i środka do zastępowania hormonami witaminy D
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
EP2124564A1
(de)
*
|
2007-01-10 |
2009-12-02 |
Bayer CropScience AG |
Insektizide düngemittelmischungen
|
US7879747B2
(en)
|
2007-03-30 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Elastic laminates having fragrance releasing properties and methods of making the same
|
EP3225243A1
(de)
|
2007-04-25 |
2017-10-04 |
Opko Renal, LLC |
Verfahren zur sicheren und effektiven behandlung und vorbeugung von sekundärem hyperparathyroidismus für chronische nierenerkrankung
|
CN104257667B
(zh)
|
2007-04-25 |
2019-06-04 |
欧普科Ip 控股Ii 有限公司 |
治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
|
PL2481400T3
(pl)
|
2007-04-25 |
2015-04-30 |
Opko Ip Holdings Ii Inc |
Sposoby i kompozycje dawki doustnej do kontrolowanego uwalniania związku będącego witaminą D
|
US8007707B1
(en)
|
2007-05-15 |
2011-08-30 |
Fresh Products, Inc. |
Method of manufacture air freshening article
|
EP2200613B1
(de)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazin-derivate und ihre verwendungen
|
EP2057984B1
(de)
*
|
2007-11-09 |
2010-01-20 |
Acino Pharma AG |
Retardtabletten mit Hydromorphon
|
JP2011506318A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
経口医薬製剤
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
US8404260B2
(en)
|
2008-04-02 |
2013-03-26 |
Bayer Cropscience Lp |
Synergistic pesticide compositions
|
ES2954932T3
(es)
|
2008-04-02 |
2023-11-27 |
Eirgen Pharma Ltd |
Métodos, composiciones, usos y kits útiles para la deficiencia de vitamina D y trastornos relacionados
|
DE102008021473A1
(de)
*
|
2008-04-29 |
2009-11-12 |
Heraeus Kulzer Gmbh |
Mit Antiplaque-Wirkstoff(en) ausgestattete Dentalmaterialien
|
US7883638B2
(en)
|
2008-05-27 |
2011-02-08 |
Dober Chemical Corporation |
Controlled release cooling additive compositions
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
CN102245171A
(zh)
*
|
2008-11-10 |
2011-11-16 |
株式会社爱茉莉太平洋 |
缓释微粒及其制备方法
|
WO2010099508A1
(en)
|
2009-02-26 |
2010-09-02 |
Theraquest Biosciences, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
MX347106B
(es)
|
2009-03-10 |
2017-04-12 |
Euro-Celtique S A * |
Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CN105796530A
(zh)
|
2010-03-29 |
2016-07-27 |
赛特克罗公司 |
用于降低甲状旁腺水平的方法和组合物
|
US20120090366A1
(en)
|
2010-04-16 |
2012-04-19 |
Taylor Pursell |
Controlled release fertilizer with biopolymer coating and process for making same
|
EP2568977A1
(de)
|
2010-05-11 |
2013-03-20 |
Cima Labs Inc. |
Alkoholresistente metoprololhaltige orale retard-dosierformen
|
JP6272695B2
(ja)
|
2010-09-01 |
2018-01-31 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
体重管理のために有用な5−ht2cアゴニストの改変放出剤形
|
KR101572336B1
(ko)
|
2010-12-22 |
2015-11-26 |
퍼듀 퍼머 엘피 |
케이싱된 탬퍼 저항성 제어 방출 투여 형태
|
CN103327969A
(zh)
|
2010-12-23 |
2013-09-25 |
普渡制药公司 |
抗篡改固体口服剂型
|
ES2628303T3
(es)
*
|
2011-06-01 |
2017-08-02 |
Fmc Corporation |
Formas de dosis sólidas de liberación controlada
|
US9243394B2
(en)
|
2011-09-20 |
2016-01-26 |
Fresh Products, Inc. |
Replaceable restroom urinal assemblies, including urinal screens
|
EP2763663B1
(de)
*
|
2011-10-06 |
2017-12-27 |
Novartis AG |
Pharmazeutische zusammensetzungen mit 40-o-(2-hydroxy)ethyl-rapamycin
|
WO2013126552A1
(en)
|
2012-02-21 |
2013-08-29 |
Auburn University |
Buprenorphine nanoparticle composition and methods thereof
|
AR092820A1
(es)
|
2012-04-17 |
2015-05-06 |
Purdue Pharma Lp |
Sistemas y metodos para tratar una respuesta farmacodinamica adversa inducida por opioides, unidad de dosis, kit
|
PL2872121T3
(pl)
|
2012-07-12 |
2019-02-28 |
SpecGx LLC |
Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
|
EA029925B1
(ru)
|
2012-07-16 |
2018-05-31 |
Родс Текнолоджис |
Способ усовершенствованного синтеза опиоидов
|
US10316042B2
(en)
|
2012-07-16 |
2019-06-11 |
Rhodes Technologies |
Process for improved opioid synthesis
|
EA201500742A1
(ru)
|
2013-02-05 |
2015-12-30 |
Пердью Фарма Л.П. |
Защищенные от нецелевого использования фармацевтические композиции
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 d 방출 제형
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
EP3024461B1
(de)
|
2013-07-23 |
2020-05-13 |
Euro-Celtique S.A. |
Kombination aus oxycodon und naloxon für die verwendung bei der behandlung von schmerzen bei patienten mit schmerzen und einer krankheit, die zur intestinaldysbiose und/oder erhöhung der gefahr bakterieller translokation führt
|
RU2637934C2
(ru)
|
2013-08-02 |
2017-12-08 |
Джонсон Мэтти Паблик Лимитед Компани |
Способ получения оксиморфона
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
CA2937006C
(en)
|
2014-01-15 |
2018-12-04 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
MX2016009125A
(es)
|
2014-01-15 |
2017-02-02 |
Rhodes Tech |
Proceso para la sintesis mejorada de oximorfona.
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
EP2937096B1
(de)
|
2014-04-23 |
2019-08-21 |
Julius-Maximilians-Universität Würzburg |
Aus RS1 abgeleitete Peptide, die Glukoseabsorption nach einer glukosereichen Mahlzeit herunterregulieren und die Insulinsensitivität steigern
|
US10258583B2
(en)
|
2014-05-01 |
2019-04-16 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of guanfacine
|
AU2015254875A1
(en)
|
2014-05-01 |
2016-11-17 |
Sun Pharmaceutical Industries Limited |
Extended release suspension compositions
|
US9962336B2
(en)
|
2014-05-01 |
2018-05-08 |
Sun Pharmaceutical Industries Limited |
Extended release suspension compositions
|
US20180104197A9
(en)
*
|
2014-05-01 |
2018-04-19 |
Sun Pharmaceutical Industries Limited |
Extended release liquid compositions of metformin
|
US10285908B2
(en)
|
2014-07-30 |
2019-05-14 |
Sun Pharmaceutical Industries Ltd |
Dual-chamber pack
|
EP3193925A2
(de)
|
2014-08-07 |
2017-07-26 |
OPKO Ireland Global Holdings, Ltd. |
Adjunktive therapie mit 25-hydroxyvitamin d
|
US20170182070A1
(en)
|
2014-10-08 |
2017-06-29 |
Mayne Pharma International Pty Ltd. |
Controlled Release Doxycycline
|
US9849124B2
(en)
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
DE202015102279U1
(de)
|
2014-11-05 |
2015-08-14 |
Fresh Products, Inc. |
Urinalsieb
|
USD778411S1
(en)
|
2014-11-05 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
USD778412S1
(en)
|
2014-11-10 |
2017-02-07 |
Fresh Products, Inc. |
Urinal screen
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
MX2017014776A
(es)
|
2015-05-20 |
2018-02-15 |
Novartis Ag |
Combinacion farmaceutica de everolimus con dactolisib.
|
US10004749B2
(en)
|
2015-07-22 |
2018-06-26 |
John Hsu |
Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
|
MX2018011820A
(es)
|
2016-03-28 |
2019-01-24 |
Opko Ireland Global Holdings Ltd |
Metodos de tratamiento con vitamina d.
|
US10369078B2
(en)
|
2016-05-02 |
2019-08-06 |
Sun Pharmaceutical Industries Limited |
Dual-chamber pack for pharmaceutical compositions
|
US10238803B2
(en)
|
2016-05-02 |
2019-03-26 |
Sun Pharmaceutical Industries Limited |
Drug delivery device for pharmaceutical compositions
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
KR20190089005A
(ko)
|
2016-11-23 |
2019-07-29 |
노파르티스 아게 |
에베롤리무스, 닥톨리십 또는 둘 다를 사용하여 면역 반응을 증진시키는 방법
|
MX2020006545A
(es)
|
2017-12-20 |
2020-09-14 |
Fresh Prod Inc |
Pantallas para mingitorios.
|
WO2019157516A1
(en)
|
2018-02-12 |
2019-08-15 |
resTORbio, Inc. |
Combination therapies
|
CN108958335B
(zh)
*
|
2018-07-27 |
2021-08-24 |
中国兵器工业第五九研究所 |
一种气候模块化数控贮存试验系统
|
USD925009S1
(en)
|
2018-10-25 |
2021-07-13 |
Fresh Products, Inc. |
Urinal screen
|
WO2020225773A1
(en)
|
2019-05-07 |
2020-11-12 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
AU2021255829A1
(en)
*
|
2020-04-13 |
2022-10-13 |
Aki, Inc. |
Disposable diffusing collar stay
|
CA3206383A1
(en)
|
2021-02-02 |
2022-08-11 |
Sangmesh TORNE |
An aqueous gel composition comprising an ethylcellulose
|
CN115844854A
(zh)
*
|
2022-10-26 |
2023-03-28 |
沈阳药科大学 |
一种微囊型自悬浮茶碱缓释颗粒及其制备方法
|